Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Jilin Northeast Asia Pharmaceutical is a Chinese pharmaceutical company specializing in the research, development, and manufacturing of both modern chemical drugs and Traditional Chinese Medicines (TCM). Based in Dunhua, Jilin Province, the company operates large-scale production facilities that comply with national GMP standards, producing a wide range of dosage forms including tablets, capsules, and granules. Its product portfolio primarily targets cardiovascular and cerebrovascular health, digestive system disorders, and respiratory conditions. The company is recognized as a key industrial enterprise in the region, focusing on the integration of natural resources from the Changbai Mountains into its pharmaceutical offerings.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Jilin Province Northeast Asia Pharmaceutical.